Accendra Health scraps ATM program, sells non-core assets for $45M, targets CEO successor by mid-September

ACCENDRA HEALTH INC/VA/

Company will not implement at-the-market equity program; no impact on results or published guidance.
Two non-core asset sales: first closed in Q3, second expected by year-end; ~$45M combined cash in Q3/Q4.
Undrawn on $300M revolving credit facility at end of Q2; confident in liquidity position.
CEO Pesicka to retire by end of 2026; Board expects to name successor by mid-September 2026.
Pesicka remains CEO until successor in place, then advisory role for orderly transition.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.